Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Q2 Revenues Rise 21 Percent

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its second-quarter revenues rose 21 percent, or 11 percent excluding the effects of currency translation and acquisitions.
 
The Waltham, Mass.-based firm generated revenues of $528.6 million for the three-month period ended June 29, compared to revenues of $437.3 million for the comparable period of 2007. Sales for its Life and Analytical Sciences segment rose 22 percent to $397.1 million from $326.3 million year over year, while sales for the Optoelectronics unit climbed 19 percent to $131.6 million from $111 million.
 
PerkinElmer posted a profit of $23.7 million, or $.20 per share, compared to net earnings of $33.7 million, or $.28 per share, in the second quarter of 2007. This year’s results include a $6.8 million loss related to discontinued operations, while last year’s results included a $15.3 million gain on the settlement of an insurance claim.
 
The firm’s R&D costs increased 9.5 percent to $29.9 million from $27.3 million, while its SG&A costs climbed 30.7 percent to $143 million from $109.4 million.
 
PerkinElmer finished the quarter with $193.5 million in cash and cash equivalents.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.